PROM1 and glioblastoma: On the other hand, several studies have proved that TFG-β facilitates the stem-like phenotype in solid tumors (e.g., breast cancer, glioblastoma, and leukemia) [36] by increasing CD133 and CD44 expression, thereby potentiating the stem-like populations.